3l8v
From Proteopedia
Line 1: | Line 1: | ||
- | + | {{Seed}} | |
+ | [[Image:3l8v.jpg|left|200px]] | ||
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_3l8v", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_3l8v| PDB=3l8v | SCENE= }} | ||
- | + | ===Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-MET in complex with a biarylamine based inhibitor=== | |
- | Description: Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-MET in complex with a biarylamine based inhibitor | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | <!-- |
+ | The line below this paragraph, {{ABSTRACT_PUBMED_20382527}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 20382527 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_20382527}} | ||
+ | |||
+ | ==Disease== | ||
+ | Known disease associated with this structure: Hepatocellular carcinoma, childhood type OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=164860 164860]], Renal cell carcinoma, papillary, familial and sporadic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=164860 164860]], Autism, suseptibility to, 9 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=164860 164860]] | ||
+ | |||
+ | ==About this Structure== | ||
+ | 3L8V is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3L8V OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:20382527</ref><references group="xtra"/> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Receptor protein-tyrosine kinase]] | ||
+ | [[Category: Sack, J.]] | ||
+ | [[Category: Alternative splicing]] | ||
+ | [[Category: Atp-binding]] | ||
+ | [[Category: Chromosomal rearrangement]] | ||
+ | [[Category: Disease mutation]] | ||
+ | [[Category: Disulfide bond]] | ||
+ | [[Category: Glycoprotein]] | ||
+ | [[Category: Grb2]] | ||
+ | [[Category: Kinase]] | ||
+ | [[Category: Membrane]] | ||
+ | [[Category: Nucleotide-binding]] | ||
+ | [[Category: Phosphoprotein]] | ||
+ | [[Category: Polymorphism]] | ||
+ | [[Category: Proto-oncogene]] | ||
+ | [[Category: Receptor]] | ||
+ | [[Category: Receptor tyrosine kinase]] | ||
+ | [[Category: Shc]] | ||
+ | [[Category: Signal transduction]] | ||
+ | [[Category: Transferase]] | ||
+ | [[Category: Transmembrane]] | ||
+ | [[Category: Tyrosine-protein kinase]] | ||
+ | |||
+ | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed May 5 11:58:17 2010'' |
Revision as of 08:58, 5 May 2010
Contents |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-MET in complex with a biarylamine based inhibitor
Template:ABSTRACT PUBMED 20382527
Disease
Known disease associated with this structure: Hepatocellular carcinoma, childhood type OMIM:[164860], Renal cell carcinoma, papillary, familial and sporadic OMIM:[164860], Autism, suseptibility to, 9 OMIM:[164860]
About this Structure
3L8V is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Williams DK, Chen XT, Tarby C, Kaltenbach R, Cai ZW, Tokarski JS, An Y, Sack JS, Wautlet B, Gullo-Brown J, Henley BJ, Jeyaseelan R, Kellar K, Manne V, Trainor GL, Lombardo LJ, Fargnoli J, Borzilleri RM. Design, synthesis and structure-activity relationships of novel biarylamine-based Met kinase inhibitors. Bioorg Med Chem Lett. 2010 May 1;20(9):2998-3002. Epub 2010 Jan 20. PMID:20382527 doi:10.1016/j.bmcl.2010.01.042
Page seeded by OCA on Wed May 5 11:58:17 2010
Categories: Homo sapiens | Receptor protein-tyrosine kinase | Sack, J. | Alternative splicing | Atp-binding | Chromosomal rearrangement | Disease mutation | Disulfide bond | Glycoprotein | Grb2 | Kinase | Membrane | Nucleotide-binding | Phosphoprotein | Polymorphism | Proto-oncogene | Receptor | Receptor tyrosine kinase | Shc | Signal transduction | Transferase | Transmembrane | Tyrosine-protein kinase